LIVTENCITY cpr pell 200 mg fl 56 pce
7680684920028
CH-68492
J05AX10
08.03.0.
Active substances:
1 / 3
google
Details
- Product number
- 6849201
- CPT
- -
- Packaging group
- 56
- Unit
- Tablette(n)
- Composition
- maribavirum 200 mg, cellulosum microcristallinum, carboxymethylamylum natricum A, magnesii stearas, Überzug: poly(alcohol vinylicus) macrogolum 3350 E 171 talcum E 133 pro compresso obducto corresp. natrium max. 0.105 mg.
Articles (1)
Livtencity 200 mg, Filmtabletten
Filmtabletten
56
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
maribavirum
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
carboxymethylamylum natricum A
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
poly(alcohol vinylicus)
|
- | Substance | HNIDK |
|
macrogolum 3350
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
talcum
|
- | Substance | HNIDK |
|
E 133
|
- | Substance | FIMDK |
|
natrium
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 11131.35
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2024
Authorization holder
Takeda Pharma AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 68492
- Drug name
- Livtencity, Filmtabletten
- Galenic form
- FILM
- ATC Code
- J05AX10
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 19/07/2023
- Authorization expiration date
- 18/07/2028
- IT number
- 08.03.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LIVTENCITY cpr pell 200 mg fl 56 pce
- Description (DE)
- LIVTENCITY Filmtabl 200 mg Fl 56 Stk
- Market launch
- 19/07/2023
- Narcotic (BTM)
- No